Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GCB70 is a branded, clinically evaluated green coffee bean extract standardized to contain 70% chlorogenic acids (notably high in 5-caffeoylquinic acid) and less than 1% caffeine. It is marketed as a natural plant concentrate for healthy weight management and metabolic support. Clinical studies have shown that supplementation with GCB70 can significantly reduce body weight, BMI, waist circumference, plasma leptin levels, fasting glucose levels, HbA1c, and thyroid-stimulating hormone (TSH) over a period of 12 weeks in overweight or obese adults. The product has demonstrated broad-spectrum safety in clinical trials. Its primary mechanism is attributed to the effects of chlorogenic acids on glucose metabolism and fat oxidation[1][2][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on GCB70.